Cullinan Oncology Inc

NASDAQ:CGEM   3:59:41 PM EDT
31.23
-0.86 (-2.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.36B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$19 Million
Adjusted EPS-$0.07
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Cullinan Oncology Inc Stock, NASDAQ:CGEM

One Main Street, Suite 520, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.410.4650
Number of Employees: 24

Description

Cullinan Oncology, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.